Literature DB >> 23399550

Glycoprotein disease markers and single protein-omics.

Kevin Chandler1, Radoslav Goldman.   

Abstract

Glycoproteins are well represented among biomarkers for inflammatory and cancer diseases. Secreted and membrane-associated glycoproteins make excellent targets for noninvasive detection. In this review, we discuss clinically applicable markers of cancer diseases and methods for their analysis. High throughput discovery continues to supply marker candidates with unusual glycan structures, altered glycoprotein abundance, or distribution of site-specific glycoforms. Improved analytical methods are needed to unlock the potential of these discoveries in validated clinical assays. A new generation of targeted quantitative assays is expected to advance the use of glycoproteins in early detection of diseases, molecular disease classification, and monitoring of therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399550      PMCID: PMC3617330          DOI: 10.1074/mcp.R112.026930

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  111 in total

1.  Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.

Authors:  M Gion; R Mione; A E Leon; R Dittadi
Journal:  Clin Chem       Date:  1999-05       Impact factor: 8.327

2.  High-throughput quantitative N-glycan analysis of glycoproteins.

Authors:  Margaret Doherty; Ciara A McManus; Rebecca Duke; Pauline M Rudd
Journal:  Methods Mol Biol       Date:  2012

3.  Non A non B and Lewis related antigens in normal human prostates: an immunohistological study of 20 anti-glycoconjugate monoclonal antibodies.

Authors:  N Daher; J Bara; M D Moubarak
Journal:  Rev Fr Transfus Immunohematol       Date:  1987-12

Review 4.  Tumor-associated carbohydrate antigens.

Authors:  S Hakomori
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

5.  Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.

Authors:  Y Mita; Y Aoyagi; T Suda; H Asakura
Journal:  J Hepatol       Date:  2000-06       Impact factor: 25.083

6.  Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae.

Authors:  J Bara; R Gautier; N Daher; H Zaghouani; C Decaens
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 7.  N-Glycans in cancer progression.

Authors:  Ken S Lau; James W Dennis
Journal:  Glycobiology       Date:  2008-08-13       Impact factor: 4.313

8.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Authors:  Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

9.  Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum.

Authors:  Irene van den Broek; Rolf W Sparidans; Jan H M Schellens; Jos H Beijnen
Journal:  Rapid Commun Mass Spectrom       Date:  2008-09       Impact factor: 2.419

10.  Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigen.

Authors:  A Nagata; N Hirota; T Sakai; M Fujimoto; T Komoda
Journal:  Tumour Biol       Date:  1991
View more
  15 in total

Review 1.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways.

Authors:  Hudson H Freeze; Jessica X Chong; Michael J Bamshad; Bobby G Ng
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

2.  Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation.

Authors:  Miloslav Sanda; Lihua Zhang; Nathan J Edwards; Radoslav Goldman
Journal:  Anal Bioanal Chem       Date:  2016-11-07       Impact factor: 4.142

3.  Data Independent Analysis of IgG Glycoforms in Samples of Unfractionated Human Plasma.

Authors:  Miloslav Sanda; Radoslav Goldman
Journal:  Anal Chem       Date:  2016-09-29       Impact factor: 6.986

Review 4.  Targeted methods for quantitative analysis of protein glycosylation.

Authors:  Radoslav Goldman; Miloslav Sanda
Journal:  Proteomics Clin Appl       Date:  2015-01-19       Impact factor: 3.494

5.  Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.

Authors:  Vilde D Haakensen; Israel Steinfeld; Radka Saldova; Akram Asadi Shehni; Ilona Kifer; Bjørn Naume; Pauline M Rudd; Anne-Lise Børresen-Dale; Zohar Yakhini
Journal:  Mol Oncol       Date:  2015-08-19       Impact factor: 6.603

Review 6.  Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomics.

Authors:  Emil Paleček; Jan Tkáč; Martin Bartošík; Tomáš Bertók; Veronika Ostatná; Jan Paleček
Journal:  Chem Rev       Date:  2015-02-09       Impact factor: 60.622

7.  The glycan role in the glycopeptide immunogenicity revealed by atomistic simulations and spectroscopic experiments on the multiple sclerosis biomarker CSF114(Glc).

Authors:  Agostino Bruno; Mario Scrima; Ettore Novellino; Gerardino D'Errico; Anna Maria D'Ursi; Vittorio Limongelli
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

8.  Enhancing Comprehensive Analysis of Secreted Glycoproteins from Cultured Cells without Serum Starvation.

Authors:  Suttipong Suttapitugsakul; Ming Tong; Fangxu Sun; Ronghu Wu
Journal:  Anal Chem       Date:  2021-01-04       Impact factor: 6.986

Review 9.  Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery.

Authors:  Ying Zhang; Jing Jiao; Pengyuan Yang; Haojie Lu
Journal:  Clin Proteomics       Date:  2014-05-05       Impact factor: 3.988

10.  Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease.

Authors:  Julius Benicky; Miloslav Sanda; Petr Pompach; Jing Wu; Radoslav Goldman
Journal:  Anal Chem       Date:  2014-10-24       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.